Integrated Filing — IndAS
General information about company
| Scrip Code |
540879 |
| NSE Symbol |
APOLLO |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE713T01028 |
| Name of company |
APOLLO MICRO SYSTEMS LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
09-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
02-02-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Third quarter |
| Nature of report standalone or consolidated |
Standalone |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Single segment |
| Description of single segment |
Electromechanical components and systems and allied components and services |
| Start date and time of board meeting |
09-02-2026 11:30:00 |
| End date and time of board meeting |
09-02-2026 15:20:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue,
preferential issue, qualified institutions placement etc. is applicable to the company for the
current quarter? |
Yes |
| No. of times funds raised during the quarter |
5 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the
entity? |
No |
| Not Applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
| 1 |
Income |
|
Revenue from operations |
20,078.39 |
55,963.14 |
|
Other income |
441.85 |
893.12 |
|
Total income |
20,520.24 |
56,856.26 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
15,428.17 |
43,416.92 |
| (b) |
Purchases of stock-in-trade |
0.00 |
0.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
1,935.65 |
(6,162.32) |
| (d) |
Employee benefit expense |
684.75 |
1,887.68 |
| (e) |
Finance costs |
870.77 |
2,885.44 |
| (f) |
Depreciation, depletion and amortisation expense
|
513.45 |
1,436.35 |
| (f) |
Other Expenses |
| 1 |
Business development expenses |
16.81 |
47.16 |
| 2 |
Consultancy charges |
127.63 |
342.89 |
| 3 |
Travelling expenses |
70.44 |
203.94 |
| 4 |
Power and fuel |
23.13 |
67.25 |
| 5 |
Rent |
4.35 |
13.05 |
| 6 |
Insurance |
36.12 |
107.26 |
| 7 |
Filing Fee |
0.10 |
0.55 |
| 8 |
Conveyance |
15.72 |
48.78 |
| 9 |
Office maintenance |
24.59 |
55.38 |
| 10 |
Other Expenses |
254.04 |
585.87 |
|
Total other expenses |
572.93 |
1,472.13 |
|
Total expenses |
20,005.72 |
44,936.20 |
| 3 |
Total profit before exceptional items and tax |
514.52 |
11,920.06 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
514.52 |
11,920.06 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
587.52 |
2,224.41 |
| 8 |
Deferred tax |
732.27 |
1,382.50 |
| 9 |
Total tax expenses |
1,319.79 |
3,606.91 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
(805.27) |
8,313.15 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
(805.27) |
8,313.15 |
| 17 |
Other comprehensive income net of taxes |
15.04 |
15.04 |
| 18 |
Total Comprehensive Income for the period |
(790.23) |
8,328.19 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
|
|
|
Total profit or loss, attributable to non-controlling interests |
|
|
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
|
|
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
|
|
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
3,572.92 |
3,572.92 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
0.93 |
2.51 |
|
Diluted earnings (loss) per share from continuing operations |
0.91 |
2.47 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
0.93 |
2.51 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
0.91 |
2.47 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| Date of end of reporting
period |
31-12-2025 |
31-12-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Standalone |
Standalone |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Re-measurement gains/ (losses) on defined benefit plan |
21.22 |
21.22 |
| 2 |
Income tax effect |
(6.18) |
(6.18) |
|
Total Amount of items that will not be reclassified to profit and loss |
15.04 |
15.04 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
0.00 |
0.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
15.04 |
15.04 |
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
12-11-2025 |
| Amount Raised |
30,00,024.00 |
| Report filed for Quarter ended |
31-12-2025 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Acuite Ratings and Research Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
Not Applicable |
| Comments of the auditors, if any |
Not Applicable |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Working Capital Requirement |
Not Applicable |
50,000.00 |
45,477.00 |
0.00 |
0.00 |
The Company has allotted 35088 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised. |
| 2 |
Research & Development Expenditure for development of futuristic technologies |
Not Applicable |
7,500.00 |
6,821.00 |
0.00 |
0.00 |
|
| 3 |
Investment in Subsidiar(y)ies |
Not Applicable |
6,600.00 |
6,003.00 |
0.00 |
0.00 |
|
| 4 |
General Corporate Purposes |
Not Applicable |
17,508.00 |
15,924.00 |
0.00 |
0.00 |
|
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
19-11-2025 |
| Amount Raised |
5,61,64,95,000.00 |
| Report filed for Quarter ended |
31-12-2025 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Acuite Ratings and Research Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
Not Applicable |
| Comments of the auditors, if any |
Not Applicable |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Working Capital Requirement |
Not Applicable |
50,000.00 |
45,477.00 |
0.00 |
0.00 |
The Company has allotted 6569000 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized. An amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised. |
| 2 |
Research & Development Expenditure for development of futuristic technologies |
Not Applicable |
7,500.00 |
6,821.00 |
0.00 |
0.00 |
|
| 3 |
Investment in Subsidiar(y)ies |
Not Applicable |
6,600.00 |
6,003.00 |
0.00 |
0.00 |
|
| 4 |
General Corporate Purposes |
Not Applicable |
17,508.00 |
15,924.00 |
0.00 |
0.00 |
|
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (3)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
26-11-2025 |
| Amount Raised |
1,03,86,50,922.00 |
| Report filed for Quarter ended |
31-12-2025 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Acuite Ratings and Research Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
Not Applicable |
| Comments of the auditors, if any |
Not Applicable |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Working Capital Requirement |
Not Applicable |
50,000.00 |
45,477.00 |
0.00 |
0.00 |
The Company has allotted 12147964 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised. |
| 2 |
Research & Development Expenditure for development of futuristic technologies |
Not Applicable |
7,500.00 |
6,821.00 |
0.00 |
0.00 |
|
| 3 |
Investment in Subsidiar(y)ies |
Not Applicable |
6,600.00 |
6,003.00 |
0.00 |
0.00 |
|
| 4 |
General Corporate Purposes |
Not Applicable |
17,508.00 |
15,924.00 |
0.00 |
0.00 |
|
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (4)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
02-12-2025 |
| Amount Raised |
24,70,13,262.00 |
| Report filed for Quarter ended |
31-12-2025 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Acuite Ratings and Research Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
Not Applicable |
| Comments of the auditors, if any |
Not Applicable |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Working Capital Requirement |
Not Applicable |
50,000.00 |
45,477.00 |
0.00 |
0.00 |
The Company has allotted 2889044 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised. |
| 2 |
Research & Development Expenditure for development of futuristic technologies |
Not Applicable |
7,500.00 |
6,821.00 |
0.00 |
0.00 |
|
| 3 |
Investment in Subsidiar(y)ies |
Not Applicable |
6,600.00 |
6,003.00 |
0.00 |
0.00 |
|
| 4 |
General Corporate Purposes |
Not Applicable |
17,508.00 |
15,924.00 |
0.00 |
0.00 |
|
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (5)
Amount in (Lakhs)
| Mode of Fund Raising |
Preferential Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
22-12-2025 |
| Amount Raised |
10,00,008.00 |
| Report filed for Quarter ended |
31-12-2025 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Acuite Ratings and Research Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
Not Applicable |
| Comments of the Audit Committee after review |
Not Applicable |
| Comments of the auditors, if any |
Not Applicable |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Working Capital Requirement |
Not Applicable |
50,000.00 |
45,477.00 |
0.00 |
0.00 |
The Company has allotted 11696 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised. |
| 2 |
Research & Development Expenditure for development of futuristic technologies |
Not Applicable |
7,500.00 |
6,821.00 |
0.00 |
0.00 |
|
| 3 |
Investment in Subsidiar(y)ies |
Not Applicable |
6,600.00 |
6,003.00 |
0.00 |
0.00 |
|
| 4 |
General Corporate Purposes |
Not Applicable |
17,508.00 |
15,924.00 |
0.00 |
0.00 |
|
Signatory Details
| Name of signatory |
Karunakar Reddy Baddam |
| Designation of person |
Managing Director |
| Place |
Hyderabad |
| Date |
09-02-2026 |